Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Efficacy of novel antibacterial compounds targeting histidine kinase YycG protein.

Liu H, Zhao D, Chang J, Yan L, Zhao F, Wu Y, Xu T, Gong T, Chen L, He N, Wu Y, Han S, Qu D.

Appl Microbiol Biotechnol. 2014 Jul;98(13):6003-13. doi: 10.1007/s00253-014-5685-8. Epub 2014 Apr 17.

2.

Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.

Liu H, Zhao Y, Zhao D, Gong T, Wu Y, Han H, Xu T, Peschel A, Han S, Qu D.

Emerg Microbes Infect. 2015 Jan;4(1):e1. doi: 10.1038/emi.2015.1. Epub 2015 Jan 7. Erratum in: Emerg Microbes Infect. 2015 Mar;4(3):e17.

3.

Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections.

Qin Z, Zhang J, Xu B, Chen L, Wu Y, Yang X, Shen X, Molin S, Danchin A, Jiang H, Qu D.

BMC Microbiol. 2006 Nov 10;6:96.

4.

Thiazolidione derivatives targeting the histidine kinase YycG are effective against both planktonic and biofilm-associated Staphylococcus epidermidis.

Huang RZ, Zheng LK, Liu HY, Pan B, Hu J, Zhu T, Wang W, Jiang DB, Wu Y, Wu YC, Han SQ, Qu D.

Acta Pharmacol Sin. 2012 Mar;33(3):418-25. doi: 10.1038/aps.2011.166. Epub 2012 Jan 9. Erratum in: Acta Pharmacol Sin. 2013 Nov;34(11):1484.

5.

Biological evaluation of halogenated thiazolo[3,2-a]pyrimidin-3-one carboxylic acid derivatives targeting the YycG histidine kinase.

Zhao D, Chen C, Liu H, Zheng L, Tong Y, Qu D, Han S.

Eur J Med Chem. 2014 Nov 24;87:500-7. doi: 10.1016/j.ejmech.2014.09.096. Epub 2014 Oct 2.

PMID:
25282671
6.

Antimicrobial activities of YycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms.

Qin Z, Lee B, Yang L, Zhang J, Yang X, Qu D, Jiang H, Molin S.

FEMS Microbiol Lett. 2007 Aug;273(2):149-56. Epub 2007 Jun 18.

7.

Redox-active compounds with a history of human use: antistaphylococcal action and potential for repurposing as topical antibiofilm agents.

Ooi N, Eady EA, Cove JH, O'Neill AJ.

J Antimicrob Chemother. 2015 Feb;70(2):479-88. doi: 10.1093/jac/dku409. Epub 2014 Nov 3.

8.

Rhodomyrtus tomentosa (Aiton) Hassk. ethanol extract and rhodomyrtone: a potential strategy for the treatment of biofilm-forming staphylococci.

Saising J, Ongsakul M, Voravuthikunchai SP.

J Med Microbiol. 2011 Dec;60(Pt 12):1793-800. doi: 10.1099/jmm.0.033092-0. Epub 2011 Aug 4.

PMID:
21816945
9.

High in vitro antimicrobial activity of β-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis.

Liu Y, Knapp KM, Yang L, Molin S, Franzyk H, Folkesson A.

Int J Antimicrob Agents. 2013 Jan;41(1):20-7. doi: 10.1016/j.ijantimicag.2012.09.014. Epub 2012 Nov 13.

PMID:
23153961
10.

High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.

Flemming K, Klingenberg C, Cavanagh JP, Sletteng M, Stensen W, Svendsen JS, Flaegstad T.

J Antimicrob Chemother. 2009 Jan;63(1):136-45. doi: 10.1093/jac/dkn464. Epub 2008 Nov 14.

11.

Design, synthesis and antistaphylococcal activity of marine pyrrole alkaloid derivatives.

Rane RA, Sahu NU, Shah CP, Shah NK.

J Enzyme Inhib Med Chem. 2014 Jun;29(3):401-7. doi: 10.3109/14756366.2013.793183. Epub 2013 May 10.

PMID:
23663080
12.

Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.

Saginur R, Stdenis M, Ferris W, Aaron SD, Chan F, Lee C, Ramotar K.

Antimicrob Agents Chemother. 2006 Jan;50(1):55-61.

13.

Synthesis and antibiofilm activity of marine natural product-based 4-thiazolidinones derivatives.

Rane RA, Sahu NU, Shah CP.

Bioorg Med Chem Lett. 2012 Dec 1;22(23):7131-4. doi: 10.1016/j.bmcl.2012.09.073. Epub 2012 Oct 3.

PMID:
23084904
14.

Pyrrolomycins as potential anti-staphylococcal biofilms agents.

Schillaci D, Petruso S, Raimondi MV, Cusimano MG, Cascioferro S, Scalisi M, La Giglia MA, Vitale M.

Biofouling. 2010;26(4):433-8. doi: 10.1080/08927011003718673.

PMID:
20234952
15.

In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections.

Molina-Manso D, del Prado G, Ortiz-Pérez A, Manrubia-Cobo M, Gómez-Barrena E, Cordero-Ampuero J, Esteban J.

Int J Antimicrob Agents. 2013 Jun;41(6):521-3. doi: 10.1016/j.ijantimicag.2013.02.018. Epub 2013 Apr 20.

PMID:
23611308
16.

Telavancin shows superior activity to vancomycin with multidrug-resistant Staphylococcus aureus in a range of in vitro biofilm models.

Smith K, Gemmell CG, Lang S.

Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1327-32. doi: 10.1007/s10096-013-1883-z. Epub 2013 Apr 29.

PMID:
23624635
17.

Effect of proteases against biofilms of Staphylococcus aureus and Staphylococcus epidermidis.

Elchinger PH, Delattre C, Faure S, Roy O, Badel S, Bernardi T, Taillefumier C, Michaud P.

Lett Appl Microbiol. 2014 Nov;59(5):507-13. doi: 10.1111/lam.12305. Epub 2014 Jul 23.

PMID:
25041576
18.

Effect of cinnamon oil on icaA expression and biofilm formation by Staphylococcus epidermidis.

Nuryastuti T, van der Mei HC, Busscher HJ, Iravati S, Aman AT, Krom BP.

Appl Environ Microbiol. 2009 Nov;75(21):6850-5. doi: 10.1128/AEM.00875-09. Epub 2009 Sep 11.

19.

Discovery of quinoline small molecules with potent dispersal activity against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a scaffold hopping strategy.

Abouelhassan Y, Garrison AT, Burch GM, Wong W, Norwood VM 4th, Huigens RW 3rd.

Bioorg Med Chem Lett. 2014 Nov 1;24(21):5076-80. doi: 10.1016/j.bmcl.2014.09.009. Epub 2014 Sep 15.

PMID:
25264073
20.

Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays.

Abbanat D, Shang W, Amsler K, Santoro C, Baum E, Crespo-Carbone S, Lynch AS.

Int J Antimicrob Agents. 2014 Jan;43(1):32-9. doi: 10.1016/j.ijantimicag.2013.09.013. Epub 2013 Oct 24.

PMID:
24252780
Items per page

Supplemental Content

Write to the Help Desk